naltrexone has been researched along with glutamic acid in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (30.56) | 18.2507 |
| 2000's | 13 (36.11) | 29.6817 |
| 2010's | 11 (30.56) | 24.3611 |
| 2020's | 1 (2.78) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Pinnock, RD | 1 |
| Chalmers, J; Drolet, G; Morilak, DA | 1 |
| Brotchie, JM; Crossman, AR; Maneuf, YP; Mitchell, IJ; Woodruff, GN | 1 |
| Faden, AI; Graham, SH; Newman, A; Shimizu, H; Weinstein, P | 1 |
| Chavkin, C; Terman, GW; Wagner, JJ | 1 |
| Donahue, BB; Hammond, DL; Stewart, PE | 1 |
| McGinty, JF; Rawls, SM | 2 |
| Brotchie, JM; Hill, MP | 1 |
| McGinty, JF; Rawls, SM; Terrian, DM | 1 |
| Gray, AM; McGinty, JF; Rawls, SM; Shippenberg, TS | 1 |
| Becker, A; Grecksch, G; Höllt, V; Schroeder, H | 1 |
| Hjorth, SA; Jones, RM; Larson, DL; Portoghese, PS; Schwartz, TW | 1 |
| Ostermeier, AM; Schlösser, B; Schwender, D; Sutor, B | 1 |
| Haddad, GG; Xia, Y; Zhang, J | 1 |
| Armstead, WM; Kulkarni, M | 1 |
| Auerbach, SB; Tao, R | 1 |
| Chang, HK; Han, SM; Jang, MH; Kim, CJ; Kim, KA; Lee, JS; Lim, S; Park, HJ; Shim, I; Shin, MC | 1 |
| Lisi, TL; Sluka, KA; Vance, CG | 1 |
| Buonopane, A; Petrakis, IL | 1 |
| Hong, SS; Qian, H; Xia, Y; Zhang, J; Zhao, P | 1 |
| Quertemont, E; Tambour, S | 1 |
| Endo, T; Fujiwara, Y; Mizutani, R; Sanbe, A; Takagi, N; Takeo, S; Tanoue, A; Tsujimoto, G; Yamauchi, J | 1 |
| Mabrouk, OS; Marti, M; Morari, M; Salvadori, S | 1 |
| Blomenröhr, M; García-Galiano, D; Gaytan, F; Krajnc-Franken, MA; Leon, S; Manfredi-Lozano, M; Navarro, VM; Pinilla, L; Romero-Ruiz, A; Tena-Sempere, M; van Ingen Schenau, D; van Noort, PI | 1 |
| Dicken, MS; Hentges, ST; Tooker, RE | 1 |
| Bäckman, CM; Chefer, V; Counotte, DS; O'Donnell, P; Oh, E; Ramamoorthy, S; Schultz-Kuszak, KN; Shippenberg, TS; Tejeda, HA | 1 |
| Bakalkin, G; Bazov, I; Chefer, V; Kuzmin, A; Meis, J; Ögren, SO; Shippenberg, T | 1 |
| Hamzah, AS; Kek, TL; Mansor, NS; Mohammat, MF; Salleh, MZ; Sani, MH; Shaameri, Z; Zakaria, ZA | 1 |
| Fredriksson, I; Jardemark, K; Jayaram-Lindström, N; Nylander, E; Nyström, E; Steensland, P; Wirf, M | 1 |
| Hanks, AN; Hughes, ZA; Mejias-Aponte, C; O'Donnell, P; Scott, L; Tejeda, HA | 1 |
| Cicin-Šain, L; Kovak-Mufić, A; Marušić, S; Matošić, A; Vidrih, B | 1 |
| Diaz, MR; Przybysz, KR; Werner, DF | 1 |
| Kayashima, S; Nagase, H; Oka, JI; Saitoh, A; Soda, A; Yamada, M; Yoshizawa, K | 1 |
| Chalhoub, RM; Kalivas, PW | 1 |
4 review(s) available for naltrexone and glutamic acid
| Article | Year |
|---|---|
Pharmacotherapy of alcohol use disorders.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Amitriptyline; Antidepressive Agents, Tricyclic; Comorbidity; Disulfiram; Dopamine; Drug Interactions; Ethanol; Female; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Male; Mental Disorders; Naltrexone; Narcotics; Serotonin; Taurine | 2005 |
Preclinical and clinical pharmacology of alcohol dependence.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Disulfiram; Dopamine; GABA Modulators; Glutamic Acid; Humans; Naltrexone; Narcotic Antagonists; Serotonin; Taurine | 2007 |
NEUROBIOLOGICAL BASES OF ALCOHOL ADDICTION.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Brain; Disulfiram; Dopamine; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Minisatellite Repeats; Monoamine Oxidase; Naltrexone; Narcotic Antagonists; Neuropeptide Y; Norepinephrine; Ondansetron; Polymorphism, Genetic; Serotonin; Synaptic Transmission; Taurine | 2016 |
Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date.
Topics: Analgesics, Opioid; Animals; Behavior, Addictive; Brain; Buprenorphine; Disease Models, Animal; Endocannabinoids; Glutamic Acid; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Orexins; Reward; Secondary Prevention; Signal Transduction; Treatment Outcome | 2020 |
32 other study(ies) available for naltrexone and glutamic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Activation of kappa-opioid receptors depresses electrically evoked excitatory postsynaptic potentials on 5-HT-sensitive neurones in the rat dorsal raphé nucleus in vitro.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Afferent Pathways; Animals; Benzofurans; Bicuculline; Bombesin; Cholecystokinin; Electric Stimulation; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Evoked Potentials; Glutamates; Glutamic Acid; In Vitro Techniques; Kynurenic Acid; N-Methylaspartate; Naloxone; Naltrexone; Neurons; Picrotoxin; Prazosin; Pyrrolidines; Quinoxalines; Raphe Nuclei; Rats; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Serotonin; Synapses; Tetrodotoxin | 1992 |
Tonic opioid inhibition of the pressor region of the rostral ventrolateral medulla of rabbits is mediated by delta receptors.
Topics: Animals; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Enkephalins; Glutamates; Glutamic Acid; Hemodynamics; Male; Medulla Oblongata; Microinjections; Naltrexone; Narcotic Antagonists; Pressoreceptors; Rabbits; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu | 1990 |
Functional implications of kappa opioid receptor-mediated modulation of glutamate transmission in the output regions of the basal ganglia in rodent and primate models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Arrhythmia Agents; Basal Ganglia; Benzofurans; Callithrix; Female; Glutamic Acid; In Vitro Techniques; Male; Motor Activity; Naltrexone; Parkinson Disease, Secondary; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reserpine; Synaptic Transmission | 1995 |
Opioid receptor antagonist nalmefene stereospecifically inhibits glutamate release during global cerebral ischemia.
Topics: Animals; Aspartic Acid; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Glycine; Hippocampus; Ischemic Attack, Transient; Kinetics; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Reperfusion; Stereoisomerism; Taurine; Time Factors | 1993 |
Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus.
Topics: Action Potentials; Animals; Benzeneacetamides; Dynorphins; Glutamates; Glutamic Acid; Guinea Pigs; Hippocampus; In Vitro Techniques; Naltrexone; Neural Inhibition; Neurotransmitter Agents; Pyrrolidines; Receptors, Opioid, kappa; Synapses; Time Factors | 1993 |
Role of spinal delta1 and delta2 opioid receptors in the antinociception produced by microinjection of L-glutamate in the ventromedial medulla of the rat.
Topics: Analgesics; Animals; Benzylidene Compounds; Glutamic Acid; Isothiocyanates; Male; Medulla Oblongata; Microinjections; Naltrexone; Narcotic Antagonists; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Spinal Cord | 1997 |
Kappa receptor activation attenuates L-trans-pyrrolidine-2,4-dicarboxylic acid-evoked glutamate levels in the striatum.
Topics: Animals; Benzeneacetamides; Calcium; Corpus Striatum; Dicarboxylic Acids; Glutamic Acid; Kinetics; Male; Microdialysis; Naltrexone; Neurotransmitter Uptake Inhibitors; Perfusion; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, kappa | 1998 |
Control of glutamate release by calcium channels and kappa-opioid receptors in rodent and primate striatum.
Topics: 4-Aminopyridine; Animals; Benzofurans; Calcium Channel Blockers; Calcium Channels; Callithrix; Glutamic Acid; In Vitro Techniques; Male; Naltrexone; Narcotic Antagonists; Neostriatum; omega-Agatoxin IVA; omega-Conotoxin GVIA; Peptides; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Spider Venoms; Synaptosomes; Tetrodotoxin | 1999 |
Presynaptic kappa-opioid and muscarinic receptors inhibit the calcium-dependent component of evoked glutamate release from striatal synaptosomes.
Topics: 4-Aminopyridine; Animals; Calcium; Chelating Agents; Dicarboxylic Acids; Egtazic Acid; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Glutamic Acid; In Vitro Techniques; Male; Muscarinic Agonists; Muscarinic Antagonists; Naltrexone; Narcotic Antagonists; Neostriatum; Nerve Endings; Neurotransmitter Uptake Inhibitors; Potassium Channel Blockers; Potassium Channels; Pyrrolidines; Rats; Rats, Wistar; Receptors, Muscarinic; Receptors, Opioid, kappa; Receptors, Presynaptic; Synaptosomes | 1999 |
The kappa-opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum.
Topics: Amphetamine; Animals; Behavior, Animal; Benzeneacetamides; Calcium; Dopamine; Glutamic Acid; Male; Microdialysis; Naltrexone; Narcotic Antagonists; Neostriatum; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, kappa | 1999 |
Involvement of delta-opioid receptors in pentylenetetrazol kindling development and kindling-related processes in rats.
Topics: Animals; Convulsants; Drug Interactions; Glutamic Acid; Injections, Intraventricular; Kindling, Neurologic; Learning Disabilities; Male; Naltrexone; Narcotic Antagonists; Pentylenetetrazole; Rats; Rats, Wistar; Receptors, Opioid, delta; Seizures; Time Factors | 1999 |
Delta opioid receptors regulate calcium-dependent, amphetamine-evoked glutamate levels in the rat striatum: an in vivo microdialysis study.
Topics: Amphetamine; Animals; Calcium; Corpus Striatum; Dopamine Agents; Dopamine Antagonists; Glutamic Acid; Male; Microdialysis; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Receptors, Opioid, delta | 2000 |
Binding of norbinaltorphimine (norBNI) congeners to wild-type and mutant mu and kappa opioid receptors: molecular recognition loci for the pharmacophore and address components of kappa antagonists.
Topics: Amino Acid Substitution; Animals; Cloning, Molecular; COS Cells; Glutamic Acid; Ligands; Models, Molecular; Mutagenesis, Site-Directed; Naltrexone; Narcotic Antagonists; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship; Transfection | 2000 |
Activation of mu- and delta-opioid receptors causes presynaptic inhibition of glutamatergic excitation in neocortical neurons.
Topics: Action Potentials; Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine-2-Alanine; Excitatory Amino Acid Antagonists; Female; GABA-A Receptor Antagonists; GABA-B Receptor Antagonists; Glutamic Acid; Iontophoresis; Male; Naltrexone; Narcotic Antagonists; Neocortex; Neurons; Rats; Rats, Wistar; Receptors, AMPA; Receptors, GABA-A; Receptors, GABA-B; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, delta; Receptors, Opioid, mu; Synapses; Synaptic Transmission | 2000 |
delta-, but not mu- and kappa-, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Cells, Cultured; Cytoprotection; Embryo, Mammalian; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine-2-Alanine; Excitatory Amino Acid Agonists; Female; Glutamic Acid; L-Lactate Dehydrogenase; Naltrexone; Narcotic Antagonists; Neocortex; Neurons; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2000 |
Relationship between NOC/oFQ, dynorphin, and COX-2 activation in impaired NMDA cerebrovasodilation after brain injury.
Topics: Animals; Animals, Newborn; Brain Injuries; Cyclooxygenase 2; Dynorphins; Enzyme Activation; Female; Glutamic Acid; Indomethacin; Isoenzymes; Male; N-Methylaspartate; Naltrexone; Nitrobenzenes; Nociceptin; Opioid Peptides; Pia Mater; Prostaglandin-Endoperoxide Synthases; Sulfonamides; Superoxides; Swine; Vasodilation | 2002 |
GABAergic and glutamatergic afferents in the dorsal raphe nucleus mediate morphine-induced increases in serotonin efflux in the rat central nervous system.
Topics: Analgesics, Opioid; Animals; Central Nervous System; Excitatory Amino Acid Agonists; GABA Agonists; GABA-A Receptor Agonists; gamma-Aminobutyric Acid; Glutamic Acid; Male; Microdialysis; Microinjections; Morphine; Muscimol; Naltrexone; Narcotic Antagonists; Neurons, Afferent; Nucleus Accumbens; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Serotonin | 2002 |
Modulation of Chelidonii herba on glycine-activated and glutamate-activated ion currents in rat periaqueductal gray neurons.
Topics: Animals; Chelidonium; Dose-Response Relationship, Drug; Ethylmaleimide; Female; Glutamic Acid; Glycine; Ion Channel Gating; Male; Membrane Potentials; Naltrexone; Neurons; Nystatin; Patch-Clamp Techniques; Periaqueductal Gray; Plant Extracts; Rats; Rats, Sprague-Dawley | 2003 |
High-frequency, but not low-frequency, transcutaneous electrical nerve stimulation reduces aspartate and glutamate release in the spinal cord dorsal horn.
Topics: Animals; Arthritis, Experimental; Aspartic Acid; Carrageenan; Chromatography, High Pressure Liquid; Glutamic Acid; Joints; Microdialysis; Naltrexone; Narcotic Antagonists; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Transcutaneous Electric Nerve Stimulation | 2005 |
Rapid hypoxia preconditioning protects cortical neurons from glutamate toxicity through delta-opioid receptor.
Topics: Animals; Cells, Cultured; Cellular Senescence; Cerebral Cortex; Enkephalin, Leucine-2-Alanine; Glutamic Acid; Hypoxia; Ischemic Preconditioning; L-Lactate Dehydrogenase; N-Methylaspartate; Naltrexone; Narcotic Antagonists; Neurons; Rats; Receptors, Opioid, delta; RNA, Messenger; Time Factors; Up-Regulation | 2006 |
Alcohol preference in mice lacking the Avpr1a vasopressin receptor.
Topics: Alcohol Drinking; Amino Acids; Animals; Arginine Vasopressin; Central Nervous System Depressants; Dizocilpine Maleate; Ethanol; Excitatory Amino Acid Antagonists; Extracellular Space; Glutamic Acid; In Situ Hybridization; Mice; Mice, Inbred C57BL; Mice, Knockout; Naltrexone; Narcotic Antagonists; Receptors, N-Methyl-D-Aspartate; Receptors, Vasopressin; Sex Characteristics | 2008 |
The novel delta opioid receptor agonist UFP-512 dually modulates motor activity in hemiparkinsonian rats via control of the nigro-thalamic pathway.
Topics: Amino Acids; Animals; Antiparkinson Agents; Benzimidazoles; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Globus Pallidus; Glutamic Acid; Male; Motor Activity; Naltrexone; Narcotic Antagonists; Neural Pathways; Oligopeptides; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Substantia Nigra; Thalamus | 2009 |
Kisspeptin signaling is indispensable for neurokinin B, but not glutamate, stimulation of gonadotropin secretion in mice.
Topics: Adamantane; Animals; Dipeptides; Follicle Stimulating Hormone; Galanin-Like Peptide; Glutamic Acid; Gonadotropin-Releasing Hormone; Gonadotropins; Hypogonadism; Kisspeptins; Luteinizing Hormone; Male; Mice; Mice, Knockout; Models, Neurological; Naltrexone; Neurokinin B; Peptide Fragments; Receptors, G-Protein-Coupled; Receptors, Kisspeptin-1; Receptors, N-Methyl-D-Aspartate; Receptors, Neuropeptide; Signal Transduction; Substance P; Testosterone | 2012 |
Regulation of GABA and glutamate release from proopiomelanocortin neuron terminals in intact hypothalamic networks.
Topics: Adrenocorticotropic Hormone; Analgesics, Opioid; Animals; Channelrhodopsins; Excitatory Postsynaptic Potentials; Female; gamma-Aminobutyric Acid; Glutamic Acid; Hypothalamus; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Light; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Naltrexone; Narcotic Antagonists; Nerve Net; Neurons; Neurotransmitter Agents; Patch-Clamp Techniques; Peptides; Presynaptic Terminals; Pro-Opiomelanocortin; Quinoxalines | 2012 |
Prefrontal cortical kappa-opioid receptor modulation of local neurotransmission and conditioned place aversion.
Topics: Analgesics; Animals; Avoidance Learning; Benzeneacetamides; Dicarboxylic Acids; Dopamine; Drug Interactions; Excitatory Postsynaptic Potentials; gamma-Aminobutyric Acid; Glutamic Acid; Male; Mice; Mice, Knockout; Microinjections; Miniature Postsynaptic Potentials; Naltrexone; Narcotic Antagonists; Neurotransmitter Uptake Inhibitors; Prefrontal Cortex; Pyramidal Cells; Pyrrolidines; Rats; Receptors, Opioid, kappa; Synaptic Transmission | 2013 |
Upregulated dynorphin opioid peptides mediate alcohol-induced learning and memory impairment.
Topics: Animals; CA3 Region, Hippocampal; Central Nervous System Depressants; Dynorphins; Ethanol; Glutamic Acid; Hippocampus; Learning; Maze Learning; Memory; Microdialysis; Naltrexone; Narcotic Antagonists; Radioimmunoassay; Rats; Rats, Wistar; Receptors, Opioid, kappa; Synaptic Transmission; Up-Regulation | 2013 |
Antinociceptive activity of a synthetic oxopyrrolidine-based compound, ASH21374, and determination of its possible mechanisms.
Topics: Analgesics; Analgesics, Opioid; Animals; Aspirin; Capsaicin; Cyclic GMP; Glutamic Acid; Male; Mice; Mice, Inbred BALB C; Morphine; Motor Activity; Naloxone; Naltrexone; Nitric Oxide; Pyrrolidines; Rats, Sprague-Dawley; Receptors, Opioid | 2013 |
Evaluation of guanfacine as a potential medication for alcohol use disorder in long-term drinking rats: behavioral and electrophysiological findings.
Topics: Alcohol Deterrents; Alcohol Drinking; Alcohol-Related Disorders; Animals; Central Nervous System Depressants; Choice Behavior; Conditioning, Operant; Disease Models, Animal; Drug Evaluation, Preclinical; Drug-Seeking Behavior; Ethanol; Glutamic Acid; Guanfacine; Male; Naltrexone; Prefrontal Cortex; Pyramidal Cells; Rats, Wistar; Tissue Culture Techniques; Treatment Outcome | 2015 |
Prefrontal Cortical Kappa Opioid Receptors Attenuate Responses to Amygdala Inputs.
Topics: Analgesics, Opioid; Animals; Anti-Anxiety Agents; Anxiety; Basolateral Nuclear Complex; Benzeneacetamides; Excitatory Postsynaptic Potentials; Glutamic Acid; Hippocampus; Male; Mice, Inbred C57BL; Microelectrodes; Naltrexone; Narcotic Antagonists; Neural Pathways; Optogenetics; Prefrontal Cortex; Pyrrolidines; Random Allocation; Rats, Long-Evans; Receptors, Opioid, kappa | 2015 |
Age-dependent regulation of GABA transmission by kappa opioid receptors in the basolateral amygdala of Sprague-Dawley rats.
Topics: Aging; Animals; Basolateral Nuclear Complex; Benzeneacetamides; gamma-Aminobutyric Acid; Glutamic Acid; Inhibitory Postsynaptic Potentials; Male; Naltrexone; Pyrrolidines; Rats; Receptors, Opioid, kappa; Synaptic Transmission | 2017 |
A delta opioid receptor agonist, KNT-127, in the prelimbic medial prefrontal cortex attenuates glial glutamate transporter blocker-induced anxiety-like behavior in mice.
Topics: Amino Acid Transport System X-AG; Animals; Anti-Anxiety Agents; Anxiety; Aspartic Acid; Drug Interactions; gamma-Aminobutyric Acid; Glutamic Acid; Male; Mice; Microinjections; Morphinans; Naltrexone; Prefrontal Cortex; Receptors, Opioid, delta | 2018 |